ConductScience.org, home

Paper526402

Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.

Besterman EM and 1 other. Br J Clin Pharmacol, 1979. Cited by 9 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients. Papers, record 526402. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/526402

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Open evaluation of labetalol in the treatment of angina pectoris occurring in hypertensive patients.
PubMed
Journal
Br J Clin Pharmacol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.68
iCite
Revised in PubMed
2018-11-13
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Besterman EME M
2Spencer MM

Source PubMed

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Angina PectorisMajor topic
EthanolaminesMajor topic
HypertensionMajor topic
LabetalolMajor topic
Blood Pressure
Electrocardiography
Eye Manifestations
Female
Heart Rate
Humans
Male
Middle Aged
Physical Exertion

Source PubMed

References3

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
110,527Reflex increase in coronary vascular resistance in patients with ischemic heart disease.N Engl J Med1976https://conductscience.org/library/papers/10527PubMed
210,949Pharmacological effects of labetalol in man.Br J Clin Pharmacol1976https://conductscience.org/library/papers/10949PubMed
310,954Closing remarks: current status of labetalol.Br J Clin Pharmacol1976https://conductscience.org/library/papers/10954PubMed

Cited by6

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
7,126,388Comparative haemodynamic dose response effects of propranolol and labetalol in coronary heart disease.Br Heart J1982https://conductscience.org/library/papers/7126388PubMed
7,093,094Alternatives to beta-blockade in therapy of hypertension with angina pectoris: role of nifedipine or of labetalol.Br J Clin Pharmacol1982https://conductscience.org/library/papers/7093094PubMed
6,653,648Diazoxide and labetalol in acute hypertension during haemodialysis.Eur J Clin Pharmacol1983https://conductscience.org/library/papers/6653648PubMed
6,151,892Alpha- and beta-blockade in angina pectoris.Drugs1984https://conductscience.org/library/papers/6151892PubMed
3,154,919Role of vasodilation in the antihypertensive and antianginal effects of labetalol: implications for therapy of combined hypertension and angina.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/3154919PubMed
526,408Labetalol, an alpha- and beta-adrenoceptor-blocking agent: its use in therapeutics. A summary of the symposium.Br J Clin Pharmacol1979https://conductscience.org/library/papers/526408PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/526402

GET https://conductscience.org/api/papers/v1/526402/authors